Why Adagio Medical Holdings (ADGM) Stock Is Skyrocketing

Adagio Medical Holdings Inc ADGM shares are trading higher by 124% to $2.07 during Thursday’s session after the FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.

What To Know: Adagio Medical says the system targets drug-resistant, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic structural heart disease. The device is designed to improve VT ablation safety and outcomes.

This designation grants Adagio priority FDA review and enhanced support during the premarket phase. It also reflects promising early data from Adagio's European CRYOCURE-VT study. The device is meanwhile under investigation in the U.S. through the FULCRUM-VT trial, enrolling 206 patients.

Adagio CEO Todd Usen called the designation a major milestone, citing unmet needs in VT treatment. While already approved in Europe, the device remains investigational in the U.S., with plans to pursue premarket approval following study completion.

Read Also: What’s Going On With Avis Budget Group Stock?

How To Buy ADGM Stock

By now you're likely curious about how to participate in the market for Adagio Medical Holdings – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of Adagio Medical Holdings, which is trading at $2.23 as of publishing time, $100 would buy you 48.31 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, ADGM has a 52-week high of $9.34 and a 52-week low of $0.62.